《局部晚期非小细胞肺癌的多学科管理和可切除性STS专家共识》解读  

Interpretation of the Society of Thoracic Surgeons expert consensus on the multidisciplinary management and resectability of locally advanced non-small cell lung cancer

作　　者：韩逸超 范璟源 杜明远 黎天成 李鹤成[1] HAN Yichao;FAN Jingyuan;DU Mingyuan;LI Tiancheng;LI Hecheng(Department of Thoracic Surgery,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,200025,P.R.China)

机构地区：[1]上海交通大学医学院附属瑞金医院胸外科,上海200025

出　　处：《中国胸心血管外科临床杂志》2025年第4期453-462,共10页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

基　　金：国家自然科学基金项目(82072557,82372855);国家重点研发计划(2021YFC2500900);上海交通大学“交大之星”计划“医工交叉研究基金”(YG2023ZD04);上海市卫生健康委员会新兴交叉领域研究专项(2022JC023);上海领军人才项目;上海市自然科学基金面上项目(24ZR1446400);中国博士后科学基金面上资助(2024M752020)。

摘　　要：随着免疫治疗和靶向治疗的不断进步,局部晚期肺癌的治疗管理及手术切除评估发生了重大变化。2024年10月,美国胸外科医师协会(Society of Thoracic Surgeons,STS)发布了《局部晚期非小细胞肺癌的多学科管理和可切除性STS专家共识》,其围绕局部晚期肺癌的可切除性评估与多学科管理、新辅助(包括围术期)治疗、辅助治疗3部分内容,提供最新的见解。本文将对该共识进行解读,旨在向胸外科同道介绍STS共识的最新观点,为国内非小细胞肺癌的手术切除、多学科管理的合理实施及综合治疗模式的规范化提供参考。With the continuous advancements in immunotherapy and targeted therapy,the treatment management and surgical resection assessment of locally advanced lung cancer have undergone significant changes.In October 2024,the Society of Thoracic Surgeons(STS)released the"STS expert consensus on the multidisciplinary management and resectability of locally advanced non-small cell lung cancer",which provides the latest insights on the evaluation of resectability and multidisciplinary management of locally advanced lung cancer,neoadjuvant(including perioperative)therapy,and adjuvant therapy.This article aims to interpret this consensus,with the goal of introducing the latest perspectives of the STS consensus to thoracic surgeons and providing a reference for the rational implementation of surgical resection,multidisciplinary management,and standardized comprehensive treatment models for non-small cell lung cancer in China.

关 键 词：肺癌 手术 可切除性 围术期治疗 辅助治疗 解读 

分 类 号：R734.2[医药卫生—肿瘤]